TrialNeuro-oncology2020

Safety and efficacy of VB-111, an anticancer gene therapy, in patients with recurrent glioblastoma: results of a phase I/II study.

Andrew J Brenner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.